Anti-Aging Stack (Epitalon + GHK-Cu + SS-31)

It isn't one drug. It's three separate peptides run together, marketed by anti-ageing clinics and peptide sellers as a do-everything longevity protocol. The pitch assigns each one a job: epitalon for telomeres (the protective caps on chromosomes), GHK-Cu for skin and tissue remodelling, and SS-31 (also called elamipretide) for mitochondria, the cell's energy plants. The "three hallmarks of ageing" framing comes from sales pages, not from a trial that ever tested these three together.

The story is that ageing has multiple causes, so you should hit several at once. Epitalon is sold on the claim it switches telomerase back on and even cut mortality in human studies; GHK-Cu on its genuine skin and collagen data; SS-31 on its mitochondrial mechanism and a real pharma development programme. Clinics bundle them as a premium "cellular regeneration" package and lean hard on the idea that stacking gives "multiplicative" effects.

Look at the grades and the gaps. Epitalon (D) rests almost entirely on a single Russian research group whose dramatic mortality findings have never been independently replicated — extraordinary claims on thin, unreplicated data. GHK-Cu (C) has real human data, but it's for topical skin and wound healing; there's no human evidence that injecting it makes you biologically younger. SS-31 (B) is the most studied — it's a real drug candidate, elamipretide — but its big Phase 3 trials in mitochondrial myopathy and heart failure failed to hit their primary endpoints, which is the opposite of a longevity win. Three peptides aimed at three pathways sounds rigorous; in practice it stacks one debunked-ish mortality claim, one skin cream repurposed as an injection, and one drug that flunked its pivotal trials. And the "multiplicative synergy" line? Nobody has run a trial on the combination. The people promising it added up are usually the people selling it.

None of the three is a licensed medicine you can be prescribed for ageing in the UK. SS-31/elamipretide is an investigational drug that hasn't been approved by the MHRA. Epitalon and GHK-Cu are sold as unlicensed "research chemicals" with no regulator checking what's actually in the vial. Buying or self-injecting them sits well outside any UK clinical framework.